XML 31 R21.htm IDEA: XBRL DOCUMENT v3.21.4
Restatement of Previously Reported Financial Statements (Tables)
3 Months Ended
Mar. 31, 2021
Accounting Changes and Error Corrections [Abstract]  
Schedule of Error Corrections and Prior Period Adjustments The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported unaudited balance sheet as of March 31, 2021:
 
As of March 31, 2021
 
As Previously
Reported
   
Adjustment
   
As Restated
 
Total assets
 
$
324,159,830
           
$
324,159,830
 
Total liabilities
 
$
11,749,240
           
$
11,749,240
 
Class A ordinary shares subject to possible redemption
    307,410,580       12,589,420       320,000,000  
Preference shares
    —         —         —    
Class A ordinary shares
    230       (126     104  
Class B ordinary shares
    800       —         800  
Additional paid-in capital
    5,541,749       (5,541,749     —    
Accumulated deficit
    (542,769     (7,047,545     (7,590,314
   
 
 
   
 
 
   
 
 
 
Total shareholders’ equity (deficit)
 
$
5,000,010
   
$
(12,589,420
)
 
 
$
(7,589,410
)
 
   
 
 
   
 
 
   
 
 
 
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit)
 
$
324,159,830
   
$
—  
   
$
324,159,830
 
   
 
 
   
 
 
   
 
 
 
The Company’s statement of shareholders’ equity (deficit) has been restated to reflect the changes to the impacted shareholders’ equity accounts for the three months ended March 31, 2021 in the table below:
 
Statement of Shareholders’ Equity (Deficit) as of March 31, 2021 (unaudited)
 
As Previously
Reported
   
Adjustment
   
As Restated
 
Sale of Class A ordinary shares in initial public offering, gross
  $ 320,000,000     $ (320,000,000   $ —    
Offering costs
  $ (17,471,641   $ 17,471,641     $ —    
Sale of private placement shares to Sponsor in private placement
  $ 10,400,000     $ (10,400,000 )   $  
Shares subject to possible redemption
  $ (307,410,580   $ 307,410,580     $ —    
Sale of private placement shares to Sponsor in private placement, net of offering costs

 
$
 
 
$
10,383,883
 
 
$
10,383,883
 
Accretion of Class A ordinary shares subject to redemption
  $ —       $ (17,455,524   $ (17,455,524
   
 
 
   
 
 
   
 
 
 
Total shareholders’ equity (deficit)
  $ 5,000,010     $ (12,589,420   $ (7,589,410
   
 
 
   
 
 
   
 
 
 
The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported statement of cash flows for the three months ended March 31, 2021:
 
Form 10-Q: Three Months Ended March 31, 2021
 
   
As Previously
Reported
   
Adjustment
   
As
Restated
 
Supplemental Disclosure of Noncash Financing Activities:
                       
Initial value of Class A ordinary shares subject to possible redemption
  $ 307,243,740     $ (307,243,740   $ —    
Change in value of Class A ordinary shares subject to possible redemption
  $ 166,840     $ (166,840   $ —    
The impact to the reported amounts of weighted average shares outstanding and basic and diluted earnings per share is presented below for the three months ended March 31, 2021:
 
   
EPS for Class A ordinary shares
 
 
As Previously
Reported
   
Adjustment
   
As Restated
 
Form 10-Q (March 31, 2021) - three months ended March 31, 2021
                       
Weighted average shares outstanding
    30,725,168       (23,258,501     7,466,667  
Basic and diluted earnings per ordinary share
  $ —       $ (0.04   $ (0.04
   
   
EPS for Class B ordinary shares
 
 
As Reported
   
Adjustment
   
As Restated
 
Form 10-Q (March 31, 2021) - three months ended March 31, 2021
                       
Weighted average shares outstanding
    7,773,461       (297,461     7,476,000  
Basic and diluted earnings per ordinary share
  $ (0.07   $ 0.03     $ (0.04